BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36873735)

  • 1. METTL14 Regulates PLAGL2/
    Zhou Q; Lai X; Gao Y; Chen Q; Xu Y; Liu Y
    J Oncol; 2023; 2023():4738586. PubMed ID: 36873735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner.
    Xie Q; Li Z; Luo X; Wang D; Zhou Y; Zhao J; Gao S; Yang Y; Fu W; Kong L; Sun T
    J Transl Med; 2022 Jan; 20(1):51. PubMed ID: 35093098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL14-mediated N
    Liu Z; Sun T; Piao C; Zhang Z; Kong C
    Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of METTL14 suppresses the malignant progression of non-small cell lung cancer by reducing Twist expression.
    Yang F; Yuan WQ; Li J; Luo YQ
    Oncol Lett; 2021 Dec; 22(6):847. PubMed ID: 34733365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL14 inhibits the malignant processes of gastric cancer cells by promoting N6-methyladenosine (m6A) methylation of TAF10.
    Zhao X; Lu J; Wu W; Li J
    Heliyon; 2024 Jun; 10(11):e32014. PubMed ID: 38882361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA m6A methyltransferase METTL14 promotes the procession of non-small cell lung cancer by targeted CSF1R.
    Ren S; Xiao Y; Yang L; Hu Y
    Thorac Cancer; 2023 Jan; 14(3):254-266. PubMed ID: 36448247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL14 enhances the m6A modification level of lncRNA MSTRG.292666.16 to promote the progression of non-small cell lung cancer.
    Ji X; Wan X; Sun H; Deng Q; Meng S; Xie B; Zhou S
    Cancer Cell Int; 2024 Feb; 24(1):61. PubMed ID: 38326804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of METTL14-mediated m
    Gong S; Wang S; Shao M
    J Mol Med (Berl); 2022 Dec; 100(12):1771-1785. PubMed ID: 36352154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLAGL2 Promotes the Proliferation and Migration of Diffuse Large B-cell Lymphoma Cells via Wnt/β-catenin Pathway.
    Jin W; Wang X
    Ann Clin Lab Sci; 2022 May; 52(3):359-366. PubMed ID: 35777795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion.
    Zhang BY; Han L; Tang YF; Zhang GX; Fan XL; Zhang JJ; Xue Q; Xu ZY
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):7015-7023. PubMed ID: 32633395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL14 promotes the migration and invasion of breast cancer cells by modulating N6‑methyladenosine and hsa‑miR‑146a‑5p expression.
    Yi D; Wang R; Shi X; Xu L; Yilihamu Y; Sang J
    Oncol Rep; 2020 May; 43(5):1375-1386. PubMed ID: 32323801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL14 suppresses cancer stem cell phenotype of colorectal cancer via regulating of β-catenin/NANOG.
    Sun CL; Chen J; Xing ZW; Tao GS
    J Cancer; 2023; 14(8):1407-1416. PubMed ID: 37283789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methyltransferase like-14 suppresses growth and metastasis of non-small-cell lung cancer by decreasing LINC02747.
    Wang J; Wang S; Yang H; Wang R; Shi K; Liu Y; Dou L; Yu H
    Cancer Sci; 2024 Jun; ():. PubMed ID: 38888105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL14 Suppresses Tumor Stemness and Metastasis of Colon Cancer Cells by Modulating m6A-Modified SCD1.
    Xu D; Han S; Yue X; Xu X; Huang T
    Mol Biotechnol; 2023 Aug; ():. PubMed ID: 37592151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA RASAL2-AS1 promotes METTL14-mediated m6A methylation in the proliferation and progression of head and neck squamous cell carcinoma.
    Rong M; Zhang M; Dong F; Wu K; Cai B; Niu J; Yang L; Li Z; Lu HY
    Cancer Cell Int; 2024 Mar; 24(1):113. PubMed ID: 38528591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mettl14 Attenuates Cardiac Ischemia/Reperfusion Injury by Regulating Wnt1/β-Catenin Signaling Pathway.
    Pang P; Qu Z; Yu S; Pang X; Li X; Gao Y; Liu K; Liu Q; Wang X; Bian Y; Liu Y; Jia Y; Sun Z; Khan H; Mei Z; Bi X; Wang C; Yin X; Du Z; Du W
    Front Cell Dev Biol; 2021; 9():762853. PubMed ID: 35004673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL14-mediated N6-methyladenosine modification of Pten mRNA inhibits tumour progression in clear-cell renal cell carcinoma.
    Zhang L; Luo X; Qiao S
    Br J Cancer; 2022 Jul; 127(1):30-42. PubMed ID: 35249103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA HCP5 acts as a miR-128-3p sponge to promote the progression of multiple myeloma through activating Wnt/β-catenin/cyclin D1 signaling via PLAGL2.
    Liu Q; Ran R; Song M; Li X; Wu Z; Dai G; Xia R
    Cell Biol Toxicol; 2022 Dec; 38(6):979-993. PubMed ID: 34331612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.